about
The disclosure of diagnosis codes can breach research participants' privacyRealities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral responseThe potential and limitations of personalised medicine in primary care.Pharmacogenetics: the ethical context.Pharmacogenetics research network and knowledge base: 1st annual scientific meeting.Comparative genome analysis and pathway reconstruction.Criteria influencing the clinical uptake of pharmacogenomic strategiesEthical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.Pharmacogenomics: implications and considerations for pharmacists.Personalized medicine in psychiatry: ethical challenges and opportunities.Eating disorders, serotonin transporter polymorphisms and potential treatment response.Integrating pharmacogenetics into society: in search of a model.Ethics and research assessing the relative roles of genes and the environment.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.Genotype-based clinical trials in cardiovascular disease.After the revolution? Ethical and social challenges in 'personalized genomic medicine'Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?The 3-I framework: a framework for developing public policies regarding pharmacogenomics (PGx) testing in Canada.Privacy issues in personalized medicine.Tailored medicine: whom will it fit? The ethics of patient and disease stratification.Tailor-made pharmacotherapy: future developments and ethical challenges in the field of pharmacogenomics.Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges.Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education.A critical assessment of the role of pharmacogenomics and pharmacogenetics approaches to cardiovascular diseasesPharmacogenomics and the challenge to privacyPotential Social, Ethical and Legal Issues Raised by the Development of PharmacogeneticsAn Introduction to Pharmacogenomics and Personalized Medicine
P2860
Q28744507-2BE16CA1-9F13-44A3-98F4-AEEC0C086020Q34131354-6709554D-1EDD-4636-BFD6-D4629FE4530DQ34173696-8F329410-2966-4940-A232-76B23F5BF43EQ34224448-55206414-2970-4A43-9E8F-5A9007B0640FQ34574028-D5386C66-26BC-48E7-A701-D3A6935618BDQ34591651-2FC884F6-7A44-417E-A201-4F2E62BF5CA9Q34612133-DE79884F-4EA5-4DF1-A600-D721D5945F04Q34843224-6B6FE197-A8AD-406B-B8EF-6FC936B3D13BQ35016337-97F4021A-8EBC-43CA-ABC1-FEAE5C48658EQ35116109-82BA1A9B-2C39-4A86-8526-B42F087F7DCBQ35237132-878CB40F-B7C5-40E0-808C-BF5EB1E3FBCFQ35676891-57B4907E-2112-4288-BE2D-F45FEDAE643FQ35889615-7AD5C0CD-B8EA-40B9-8E5D-5B7F781E125EQ36090392-6F94C8E5-D733-450A-97C6-A2EB5D80AD68Q36203479-3AE92218-B7FC-4B8A-B609-E97889903B59Q36393911-F0AE791D-2327-4D65-809E-A7116FED6673Q36822356-844EE421-43AE-405E-9831-150425A11CB1Q37643815-BBA2E0D7-6898-4211-98AE-BA32CFA1AE01Q38654780-B719CEEE-5E8C-489B-81A7-3F0823375DA4Q39642852-0DF533D5-8D99-4A0D-986F-1F86B61AD3E1Q40479881-D415CD10-2B54-4225-AAF7-4F1B7EAC174AQ40479885-6D0788DD-52AF-4CE8-8CE3-B9E6D5E4A730Q40565875-5B77D80D-C546-45EF-827F-131E92D1B333Q47618340-4FA1C669-ABEE-4FC1-9836-27C279C5666DQ57605947-B72F3E5B-1FE3-4531-A8C8-98FDA548B2C6Q58064570-055A9A1D-A80B-4093-8CAB-E64C2561ABEFQ58190997-53B0455E-FF18-41F8-A67F-B9A01B071111Q58875252-86CA3472-1A9A-48F4-8F8C-31F9CBC0F4C7
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ethical and legal implications of pharmacogenomics.
@ast
Ethical and legal implications of pharmacogenomics.
@en
Ethical and legal implications of pharmacogenomics.
@nl
type
label
Ethical and legal implications of pharmacogenomics.
@ast
Ethical and legal implications of pharmacogenomics.
@en
Ethical and legal implications of pharmacogenomics.
@nl
prefLabel
Ethical and legal implications of pharmacogenomics.
@ast
Ethical and legal implications of pharmacogenomics.
@en
Ethical and legal implications of pharmacogenomics.
@nl
P2860
P356
P1476
Ethical and legal implications of pharmacogenomics.
@en
P2093
P2860
P2888
P304
P356
10.1038/35056075
P577
2001-03-01T00:00:00Z
P5875
P6179
1043443401